With the increasingly enhancing the fluidity of resources and knowledge, a staged breakthrough from inside enterprises independent R&D to cooperative innovation is stridden over in the global biopharmaceutical industry, and innovative network becomes the main organization form in R&D for the new medicine. However, the generation and evolution law of biopharmaceutical innovative network still need to the further researched. By taking Zhangjiang in Shanghai as an example, the evolution law of biopharmaceutical innovative network has been analyzed from two dimensions of cooperative innovation and collaborative learning. The result shows that cooperative innovation is the inner drive for the development of biopharmaceutical innovative network; collaborative learning accelerates the structural expansion of innovative network.With the change in geographical spatial openness and cooperative flatness, biopharmaceutical innovation network goes through the evolution of inner-enterprise innovation network, local innovation network, and global innovation networks.
Key words
biopharmaceutical innovation network /
evolution law /
Zhangjiang
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Feldman, Maryann P..Francis,Johanna L.Fortune Favours the Prepared Region: The Case of Entrepreneurship and the Capitol Region Biotechnology Cluster[J]. European Planning Studies.2003,11(7):765-788.
[2] Jason Owen-Smith,Walter W. Powell. Knowledge Networks as Channels and Conduits:The Effects of Spillovers in the Boston Biotechnology Community[J].Organization Science. 2004,15(1):5-21.
[3] 肖勤.上海浦东生物医药产业集群研究 .华东师范高校2006年硕士学位论文.
[4] Cooke, Philip. Biotechnology Clusters in the U.K.: Lessons from Localisation in the Commercialisation of Science[J]. Small Business Economics.2001,17:43-59.
[5] Vittorio Chiesa,Davide Chiaroni,Industrial Cluster in Biotechnology-Driving Forces,Dvelopment Processes and Management Practices[M].London:Imperial College Press.2005.
[6] Casper, Steven, Karamanos, Anastasios. Commericalizing Science in Europe: The Cambridge Biotechnology Cluster[J]. European Planning Studies,2003,11(7):805-822.
[7] Robert W. Rycroft.Does cooperation absorb complexity?Innovation networks and the speed and spread of complex technological innovation[J].Technological Forecasting & Social Change.2007(74):565-578.
[8] Rothwell R.Successful Industrial Innovation:Critical Factors for the 1990s[J].R&D Management,1992,22 (3):221-239.
[9] Kean Birch.Alliance-Driven Governance: Applying a Global Commodity Chains Approach to the U.K. Biotechnology Industry[J]. economic geography,2008, 84(1):83-103.
[10] Teece.David.Profiting from Technological Innovation:Implications for Integration Collaboration Licensing and Public Policy[J].Research Policy.1986,15 (6):185-219.
[11] Chandler.Alfred D.Jr.Scale and Scope:the Dynamics of Industry Capitalism[M].Cambridge,Mass.Belknap Press.1990.
[12] Hagedoorn J,Duysters G.Learning in dynamic inter-firm networks,the efficacy of quasi-redundant contacts[J].Organization Studies.2002,23(4):525-548.
[13] Steinle.C and Schiel.H.When do industries clusters? A proposal on how to assess an industry's propensity to concentration at a single region or nation .中国科学技术高校2007届博士学位论文.
[16] Gary P. Pisano and Roberto Verganti. Which Kind of Collaboration Is Right for You? Harvard Business Review.2008.
[17] 张江高科技园区.2010年度张江高科技园区产业发展报告 .2011年10月.
PDF(1104 KB)
